ArticleDigital discovery2026
FlowMol3: flow matching for 3D
Article in Digital discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Is AI Capable of Real-World Drug Discovery?Journal of chemical information and modeling · 2026Article
- FLOWR.ROOT - A flow matching-based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction.Nature communications · 2026Article
- Sampling out-of-distribution chemical spaces via Bayesian flow.Journal of cheminformatics · 2026Article
- Fast and Flexible 3D Molecular Design Framework for Novel Organic Optoelectronic Materials.JACS Au · 2026Article
- Assessing the factors influencing the quality of pocket-conditioned 3D generative models.Journal of cheminformatics · 2026Article
- Artificial intelligence in drug discovery from advanced molecular representation to pipeline applications.Frontiers in bioinformatics · 2026Review
- Diffusion Models at the Drug Discovery Frontier: A Review on Generating Small Molecules Versus Therapeutic Peptides.Biology · 2025Review
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
A generative model capable of sampling realistic molecules with desired properties could accelerate chemical discovery across a wide range of applications. Toward this goal, significant effort has focused on developing models that jointly sample molecular topology and 3D structure. We present FlowMol3, an open-source, multi-modal flow matching model that advances the state of the art for all-atom, small-molecule generation. Its substantial performance gains over previous FlowMol versions are achieved without changes to the graph neural network architecture or the underlying flow matching formulation. Instead, FlowMol3's improvements arise from three architecture-agnostic techniques that incur negligible computational cost: self-conditioning, fake atoms, and train-time geometry distortion. FlowMol3 achieves nearly 100% molecular validity for drug-like molecules with explicit hydrogens, more accurately reproduces the functional group composition and geometry of its training data, and does so with an order of magnitude fewer learnable parameters than comparable methods. We hypothesize that these techniques mitigate a general pathology affecting transport-based generative models, enabling detection and correction of distribution drift during inference. Our results highlight simple, transferable strategies for improving the stability and quality of diffusion- and flow-based molecular generative models.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.